The global knee cartilage repair market encompasses a rapidly growing sector dedicated to addressing the prevalent issue of knee joint damage and degeneration. With an increased sports-related injuries, the demand for effective cartilage repair solutions has surged. Innovative technologies such as autologous chondrocyte implantation, microfracture, and tissue engineering are driving market growth. These techniques aim to restore damaged knee cartilage, alleviate pain, and improve joint function. The market's trajectory is poised for continued growth as technology evolves, offering patients globally more effective and minimally invasive knee cartilage repair options.
Access Full Report @ https://www.databridgemarketresearch.com/zh/reports/global-knee-cartilage-repair-market
Data Bridge Market Research analyses that the Global Knee Cartilage Repair Market which was USD 2,810.00 million in 2022, is expected to reach USD 5,011.57 million by 2030, and is expected to undergo a CAGR of 7.5% during the forecast period of 2023 to 2030. The increasing global aging population is a significant factor in the rising prevalence of osteoarthritis, a primary contributor to knee cartilage damage. This demographic shift is propelling demand for effective knee cartilage repair solutions as individuals seek treatments to address the consequences of age-related joint conditions.
Key Findings of the Study
Patient preference for minimally invasive procedures is expected to drive the market's growth rate
Patients increasingly favor minimally invasive knee cartilage repair procedures due to their shorter recovery periods and decreased postoperative complications. The shift reflects a preference for treatments that involve smaller incisions, resulting in less tissue damage and faster healing. Minimally invasive approaches not only provide patients with a quicker return to normal activities but also contribute to improved overall patient satisfaction, driving the adoption of these procedures in the realm of knee cartilage repair.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Cell-based and Non-cell-based), Surgery, (Osteochondral Autograft Transplantation, Osteochondral Allograft Transplantation, Micro Fracture, Drilling, Abrasion Arthroplasty, Autologous Chondrocyte Implantation, and Others), Devices (Implants, Osteotomy, Bone Grafts, Arthroscopy, Resurfacing, Arthrodesis, and Others), Application (Osteoarthritis, Rheumatoid Arthritis, Osteonecrosis, Fractures, Bone Tumors, and Others), End-User (Hospital, Ambulatory Surgical Centers, and Independent Centers) Distribution Channel (Third Party Distributor, Online Sales, Direct Sales, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest Of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest Of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel And Rest Of Middle East And Africa, Brazil, Argentina And Rest Of South America
|
|
Market Players Covered
|
Smith+Nephew (U.K.), Stryker (U.S.), Zimmer Biomet (U.S.), B. Braun Melsungen AG (Germany),MEDIPOST (South Korea), Vericel Corporation (U.S.), CONMED Corporation (U.S.), Medical Devices Business Services (DePuy Synthes) (U.S.), Meril Life Sciences Pvt. Ltd. (India), Arthrex, Inc. (U.S.), Medacta International (Switzerland), Teijin Nakashima Medical Co., Ltd. (Japan), BioTissue SA (Switzerland), ISTO Technologies, Inc. (U.S.), CartiHeal, Inc. (Israel), Mathys AG Bettlach (Switzerland), Waldemar Link GmbH & Co.KG (Germany), JRI Orthopaedics (U.K.), Regentis Biomaterials Ltd. (Israel), Auxein Medical. (India), EVOLUTIS INDIA PVT. LTD. (India), and Japan MDM, Inc. (Japan)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global knee cartilage repair market is segmented on the basis of treatment, surgery, devices, application, end-user, and distribution channel.
- On the basis of treatment, the global knee cartilage repair market is segmented into cell-based and non-cell-based
- On the basis of surgery, the global knee cartilage repair market is segmented into osteochondral autograft transplantation, osteochondral allograft transplantation, micro fracture, drilling, abrasion arthroplasty, autologous chondrocyte implantation, and others
- On the basis of devices, the global knee cartilage repair market is segmented into implants, osteotomy, bone grafts, arthroscopy, resurfacing, arthrodesis, and others
- On the basis of application, the global knee cartilage repair market is segmented into osteoarthritis, rheumatoid arthritis, osteonecrosis, fractures, bone tumors, and others
- on the basis of end-user, the global knee cartilage repair market is segmented into hospital, ambulatory surgical centers, and independent centers
- On the basis of distribution channel, the global knee cartilage repair market is segmented into third party distributor, online sales, direct sales, and others
Major Players
Data Bridge Market Research recognizes the following companies as the major global knee cartilage repair market players in global knee cartilage repair market are CartiHeal, Inc. (Israel), Mathys AG Bettlach (Switzerland), Waldemar Link GmbH & Co.KG (Germany), JRI Orthopaedics (U.K.), Regentis Biomaterials Ltd. (Israel), Auxein Medical. (India), EVOLUTIS INDIA PVT. LTD. (India), and Japan MDM, Inc. (Japan)
Market Developments
- In March 2022, CartiHeal Ltd. achieved a significant milestone as the US FDA granted Premarket Approval (PMA) for its Agili-C implant. The implant, designed for treating cartilage and osteochondral defects in knee joints, showcases the company's commitment to advancing innovative solutions for both arthritic and non-arthritic conditions
- In February 2022, Hy2Care BV initiated a clinical trial for their injectable hydrogel as an advanced cartilage treatment. This trial aims to validate the hydrogel's effectiveness, focusing on demonstrating both clinical safety and performance in treating cartilage-related issues. The development underscores Hy2Care's dedication to pioneering injectable solutions for improved cartilage treatment outcomes
- In April 2021, Stryker collaborated with Minor League Baseball, becoming the official SmartRobotics joint replacement partner. Stryker introduced Mako SmartRobotics, utilizing 3D CT-Based planning for hip and knee replacement. This innovative technology enables surgeons to create a precise 3D image of each patient's unique anatomy, enhancing surgical precision
- In March 2021, Smith-Nephew, in partnership with Huma, developed a remote patient monitoring app for orthopedic surgery. This initiative addresses the backlog of orthopedic surgeries in the U.K., where surgeries are operating at 50% capacity due to COVID-19, leaving around 250,000 patients on waiting lists. The app facilitates surgeons in remotely monitoring and preparing patients, ensuring a more efficient and informed approach to safe surgery
Regional Analysis
Geographically, the countries covered in the global knee cartilage repair market report are U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest Of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest Of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel And Rest Of Middle East And Africa, Brazil, Argentina And Rest Of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in the global knee cartilage repair market during the forecast period 2023-2030
North America dominates the global knee cartilage repair market in market share and revenue, maintaining its stronghold through the forecast period. The region's supremacy is fueled by increasing healthcare expenditure, favorable health remuneration policies, a rise in chronic wounds, and a growing elderly population. These factors collectively contribute to a robust growth trajectory, solidifying North America's position as a key player in the knee cartilage repair market.
Asia-Pacific is estimated to be the fastest-growing region in the global knee cartilage repair market for the forecast period 2023-2030
Asia-Pacific is expected to dominate the global knee cartilage repair market, experiencing the fastest growth from 2023 to 2030. The surge is attributed to a rising number of insurance payers, fostering accessibility to advanced treatments. The region's flourishing private healthcare sector and heightened awareness among the populace are additional catalysts, propelling the market growth. These factors collectively position Asia-Pacific as a key player in driving the accelerated expansion of the knee cartilage repair market during the forecast period.
For more detailed information about the global knee cartilage repair market report, click here – https://www.databridgemarketresearch.com/zh/reports/global-knee-cartilage-repair-market
